Current Psychotropic Medication Use and Contributing Factors Among Nursing Home Residents With Cognitive Impairment

Barbara Resnick, Ann Marie Kolanowski, Kimberly Sue Van Haitsma, Elizabeth Galik, Marie P. Boltz, Jeanette Ellis, Liza Behrens, Karen Eshraghi, Shijun Zhu

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

This study described current use and predictors of psychotropics among residents with moderate to severe cognitive impairment. This was a secondary data analysis using baseline data from the first 341 residents in an ongoing trial. Predictive measures included age, gender, race, depressive symptoms, agitation, resistiveness to care, depression, cognition, pain, comorbidities, facility factors, and state. Overall 63% (n = 211) received at least one psychotropic medication, 16% (n = 52) an anti-seizure medication, 23% (n = 77) an anxiolytic, 30% (n = 99) an antidepressant, 2% (n = 8) a sedative hypnotic, 28% (n = 93) an antipsychotic medication, and 9% (n = 29) an opioid. Testing of models explained 9% to 15% of psychotropic medication use. There were high rates of psychotropic medication use and a limited association between demographic factors, behavioral symptoms, and psychotropic medication use. Continued research is needed to explore the impact of deprescribing, person-centered behavioral interventions, and beliefs of providers on psychotropic medication use.

Original languageEnglish (US)
JournalClinical Nursing Research
DOIs
StatePublished - Jan 1 2019

Fingerprint

Nursing Homes
Depression
Behavioral Symptoms
Anti-Anxiety Agents
Hypnotics and Sedatives
Cognition
Opioid Analgesics
Antidepressive Agents
Antipsychotic Agents
Comorbidity
Seizures
Demography
Pain
Research
Cognitive Dysfunction
Deprescriptions

All Science Journal Classification (ASJC) codes

  • Nursing(all)

Cite this

@article{009a5142ae914f23b68623a60ce8579e,
title = "Current Psychotropic Medication Use and Contributing Factors Among Nursing Home Residents With Cognitive Impairment",
abstract = "This study described current use and predictors of psychotropics among residents with moderate to severe cognitive impairment. This was a secondary data analysis using baseline data from the first 341 residents in an ongoing trial. Predictive measures included age, gender, race, depressive symptoms, agitation, resistiveness to care, depression, cognition, pain, comorbidities, facility factors, and state. Overall 63{\%} (n = 211) received at least one psychotropic medication, 16{\%} (n = 52) an anti-seizure medication, 23{\%} (n = 77) an anxiolytic, 30{\%} (n = 99) an antidepressant, 2{\%} (n = 8) a sedative hypnotic, 28{\%} (n = 93) an antipsychotic medication, and 9{\%} (n = 29) an opioid. Testing of models explained 9{\%} to 15{\%} of psychotropic medication use. There were high rates of psychotropic medication use and a limited association between demographic factors, behavioral symptoms, and psychotropic medication use. Continued research is needed to explore the impact of deprescribing, person-centered behavioral interventions, and beliefs of providers on psychotropic medication use.",
author = "Barbara Resnick and Kolanowski, {Ann Marie} and {Van Haitsma}, {Kimberly Sue} and Elizabeth Galik and Boltz, {Marie P.} and Jeanette Ellis and Liza Behrens and Karen Eshraghi and Shijun Zhu",
year = "2019",
month = "1",
day = "1",
doi = "10.1177/1054773819838678",
language = "English (US)",
journal = "Clinical Nursing Research",
issn = "1054-7738",
publisher = "SAGE Publications Inc.",

}

Current Psychotropic Medication Use and Contributing Factors Among Nursing Home Residents With Cognitive Impairment. / Resnick, Barbara; Kolanowski, Ann Marie; Van Haitsma, Kimberly Sue; Galik, Elizabeth; Boltz, Marie P.; Ellis, Jeanette; Behrens, Liza; Eshraghi, Karen; Zhu, Shijun.

In: Clinical Nursing Research, 01.01.2019.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Current Psychotropic Medication Use and Contributing Factors Among Nursing Home Residents With Cognitive Impairment

AU - Resnick, Barbara

AU - Kolanowski, Ann Marie

AU - Van Haitsma, Kimberly Sue

AU - Galik, Elizabeth

AU - Boltz, Marie P.

AU - Ellis, Jeanette

AU - Behrens, Liza

AU - Eshraghi, Karen

AU - Zhu, Shijun

PY - 2019/1/1

Y1 - 2019/1/1

N2 - This study described current use and predictors of psychotropics among residents with moderate to severe cognitive impairment. This was a secondary data analysis using baseline data from the first 341 residents in an ongoing trial. Predictive measures included age, gender, race, depressive symptoms, agitation, resistiveness to care, depression, cognition, pain, comorbidities, facility factors, and state. Overall 63% (n = 211) received at least one psychotropic medication, 16% (n = 52) an anti-seizure medication, 23% (n = 77) an anxiolytic, 30% (n = 99) an antidepressant, 2% (n = 8) a sedative hypnotic, 28% (n = 93) an antipsychotic medication, and 9% (n = 29) an opioid. Testing of models explained 9% to 15% of psychotropic medication use. There were high rates of psychotropic medication use and a limited association between demographic factors, behavioral symptoms, and psychotropic medication use. Continued research is needed to explore the impact of deprescribing, person-centered behavioral interventions, and beliefs of providers on psychotropic medication use.

AB - This study described current use and predictors of psychotropics among residents with moderate to severe cognitive impairment. This was a secondary data analysis using baseline data from the first 341 residents in an ongoing trial. Predictive measures included age, gender, race, depressive symptoms, agitation, resistiveness to care, depression, cognition, pain, comorbidities, facility factors, and state. Overall 63% (n = 211) received at least one psychotropic medication, 16% (n = 52) an anti-seizure medication, 23% (n = 77) an anxiolytic, 30% (n = 99) an antidepressant, 2% (n = 8) a sedative hypnotic, 28% (n = 93) an antipsychotic medication, and 9% (n = 29) an opioid. Testing of models explained 9% to 15% of psychotropic medication use. There were high rates of psychotropic medication use and a limited association between demographic factors, behavioral symptoms, and psychotropic medication use. Continued research is needed to explore the impact of deprescribing, person-centered behavioral interventions, and beliefs of providers on psychotropic medication use.

UR - http://www.scopus.com/inward/record.url?scp=85063946956&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063946956&partnerID=8YFLogxK

U2 - 10.1177/1054773819838678

DO - 10.1177/1054773819838678

M3 - Article

C2 - 30943786

AN - SCOPUS:85063946956

JO - Clinical Nursing Research

JF - Clinical Nursing Research

SN - 1054-7738

ER -